ArticleDiscover oncology2023

OSR1 downregulation indicates an unfavorable prognosis and activates the NF-κB pathway in ovarian cancer.

Zhong Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.